HESKA CORP

2023 Q2 Form 10-Q Financial Statement

#000103813323000023 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $125.2M
YoY Change -27.52%
Cash & Equivalents $125.2M
Short-Term Investments
Other Short-Term Assets $6.451M
YoY Change 2.25%
Inventory $64.18M
Prepaid Expenses $6.239M
Receivables $26.05M
Other Receivables $8.173M
Total Short-Term Assets $238.6M
YoY Change -12.51%
LONG-TERM ASSETS
Property, Plant & Equipment $55.03M
YoY Change 62.72%
Goodwill $145.4M
YoY Change 3.87%
Intangibles $65.81M
YoY Change -8.39%
Long-Term Investments $592.0K
YoY Change -70.77%
Other Assets $13.07M
YoY Change 16.06%
Total Long-Term Assets $354.1M
YoY Change 7.65%
TOTAL ASSETS
Total Short-Term Assets $238.6M
Total Long-Term Assets $354.1M
Total Assets $592.7M
YoY Change -1.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.25M
YoY Change -1.04%
Accrued Expenses $20.87M
YoY Change 5.52%
Deferred Revenue $8.400M
YoY Change -7.69%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $152.0K
YoY Change -9.52%
Total Short-Term Liabilities $42.30M
YoY Change 4.36%
LONG-TERM LIABILITIES
Long-Term Debt $96.04M
YoY Change -4.28%
Other Long-Term Liabilities $5.312M
YoY Change 3.71%
Total Long-Term Liabilities $5.312M
YoY Change 3.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $42.30M
Total Long-Term Liabilities $5.312M
Total Liabilities $175.0M
YoY Change 1.14%
SHAREHOLDERS EQUITY
Retained Earnings -$178.7M
YoY Change 12.63%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $417.7M
YoY Change
Total Liabilities & Shareholders Equity $592.7M
YoY Change -1.49%

Cashflow Statement

Concept 2023 Q2 2023 Q1

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001038133
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0192527
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
000-22427
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
HESKA CORPORATION
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3760 Rocky Mountain Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Loveland
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CO
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
80538
CY2023Q1 dei City Area Code
CityAreaCode
970
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
493-7272
CY2023Q1 dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
HSKA
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10913754 shares
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
0 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
125209000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
156618000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1190000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1129000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26054000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
29493000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
64183000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
60050000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
190000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Allowance
LoansAndLeasesReceivableAllowance
182000 usd
CY2023Q1 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
8173000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Net Of Deferred Income
LoansAndLeasesReceivableNetOfDeferredIncome
7433000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6239000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5514000 usd
CY2023Q1 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
2312000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
6451000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
5926000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
238621000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
265034000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55030000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32171000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13101000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6897000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
145403000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
135918000 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
65813000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
62393000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
31483000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
23684000 usd
CY2023Q1 hska Loans And Leases Receivable Net Of Deferred Income Noncurrent
LoansAndLeasesReceivableNetOfDeferredIncomeNoncurrent
29605000 usd
CY2022Q4 hska Loans And Leases Receivable Net Of Deferred Income Noncurrent
LoansAndLeasesReceivableNetOfDeferredIncomeNoncurrent
27499000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5137000 usd
CY2022Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
5081000 usd
CY2023Q1 us-gaap Investments
Investments
592000 usd
CY2022Q4 us-gaap Investments
Investments
3959000 usd
CY2023Q1 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
0 usd
CY2022Q4 us-gaap Notes Receivable Related Parties
NotesReceivableRelatedParties
2224000 usd
CY2023Q1 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
0 usd
CY2022Q4 us-gaap Due From Affiliate Noncurrent
DueFromAffiliateNoncurrent
13511000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13067000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12526000 usd
CY2023Q1 us-gaap Assets
Assets
592715000 usd
CY2022Q4 us-gaap Assets
Assets
585816000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12246000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16403000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20866000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15149000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4049000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2944000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
42298000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
39577000 usd
CY2023Q1 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
84579000 usd
CY2022Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
84467000 usd
CY2023Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
11130000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
11130000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5422000 usd
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
4096000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9674000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4528000 usd
CY2023Q1 hska Deferred Tax Liabilities Foreign Intangible
DeferredTaxLiabilitiesForeignIntangible
16629000 usd
CY2022Q4 hska Deferred Tax Liabilities Foreign Intangible
DeferredTaxLiabilitiesForeignIntangible
16438000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5312000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3372000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
175044000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
163608000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q1 hska Public Common Stock Value Issued
PublicCommonStockValueIssued
109000 usd
CY2022Q4 hska Public Common Stock Value Issued
PublicCommonStockValueIssued
108000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
600126000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
597139000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3906000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6506000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-178658000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-168533000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
417671000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
422208000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
592715000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
585816000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62381000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64800000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
34982000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
35655000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
27399000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
29145000 usd
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
12449000 usd
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11997000 usd
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3088000 usd
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12456000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22285000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16146000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
37822000 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
40599000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10423000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11454000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
272000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-359000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10151000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11813000 usd
CY2023Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
690000 usd
CY2022Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
158000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1065000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2366000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-375000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2208000 usd
CY2023Q1 hska Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-9776000 usd
CY2022Q1 hska Income Loss From Continuing Operations Before Equity Method Investments Noncontrolling Interest Net Of Tax
IncomeLossFromContinuingOperationsBeforeEquityMethodInvestmentsNoncontrollingInterestNetOfTax
-9605000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-349000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-381000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-10125000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9986000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10390000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10273000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10390000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10273000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-10125000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9986000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
2600000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-3043000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7525000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13029000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
435854000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-9986000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3200000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5110000 usd
CY2022Q1 hska Adjustments To Additional Paid In Capital Equity Contingent Consideration
AdjustmentsToAdditionalPaidInCapitalEquityContingentConsideration
3860000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
-3043000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
428595000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
422208000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-10125000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-89000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3077000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Net Unamortized Gain Loss Arising During Period Before Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax
2600000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
417671000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-10125000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9986000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3974000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3300000 usd
CY2023Q1 hska Operating Lease Noncash Impacts
OperatingLeaseNoncashImpacts
871000 usd
CY2022Q1 hska Operating Lease Noncash Impacts
OperatingLeaseNoncashImpacts
673000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1065000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2366000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3077000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
5110000 usd
CY2023Q1 hska Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-8000 usd
CY2022Q1 hska Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
236000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-349000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-381000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
24000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
11000 usd
CY2023Q1 hska Unrealized Gain Loss On Foreign Currency Translation
UnrealizedGainLossOnForeignCurrencyTranslation
703000 usd
CY2022Q1 hska Unrealized Gain Loss On Foreign Currency Translation
UnrealizedGainLossOnForeignCurrencyTranslation
-473000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4399000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2060000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3112000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6528000 usd
CY2023Q1 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
2708000 usd
CY2022Q1 us-gaap Increase Decrease In Leasing Receivables
IncreaseDecreaseInLeasingReceivables
2248000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1908000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
288000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-7683000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-3069000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4035000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4006000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9161000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17665000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1885000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
334000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22558000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29843000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1761000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
90000 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
4961000 usd
CY2023Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
39000 usd
CY2022Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
62000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-128000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3262000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
438000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-60000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-31409000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-50830000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156618000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
223574000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
125209000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
172744000 usd
CY2023Q1 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
1297000 usd
CY2022Q1 us-gaap Property Plant And Equipment Transfers And Changes
PropertyPlantAndEquipmentTransfersAndChanges
749000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2022Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
3860000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
11800000 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
0 usd
CY2023Q1 hska Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued Value
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedValue
2550000 usd
CY2022Q1 hska Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Shares Issued Value
NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssuedValue
1608000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates are required when establishing the allowance for credit losses and the net realizable value of inventory; determining future costs associated with warranties provided; determining the period over which our obligations are fulfilled under agreements to license product rights and/or technology rights; evaluating long-lived and intangible assets and investments for estimated useful lives and impairment; estimating the useful lives and standalone selling prices of instruments under leasing arrangements; determining the allocation of purchase price under purchase accounting; estimating the timing and probability of expense associated with the granting of performance-based stock awards; determining the need for, and the amount of a valuation allowance on deferred tax assets; determining the fair value of our embedded derivatives; determining the value of the contingent consideration in a business combination and determining the value of the non-controlling interest in a business combination. Our actual results may differ from these estimates and there may be changes to those estimates in future periods.
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
62381000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64800000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
232100000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
41087000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
52303000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
45981000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
40759000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
27638000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
24369000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
232137000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1900000 usd
CY2023Q1 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
6500000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1800000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
5900000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1500000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
5100000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8400000 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
8300000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
9600000 usd
CY2023Q1 hska Contractwith Customer Liability Increase Due To Additional Deferred Sales
ContractwithCustomerLiabilityIncreaseDueToAdditionalDeferredSales
2500000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2400000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10151000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-11813000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
592000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
941000 usd
CY2023Q1 hska Non Marketable Equity Security Investment
NonMarketableEquitySecurityInvestment
0 usd
CY2022Q4 hska Non Marketable Equity Security Investment
NonMarketableEquitySecurityInvestment
3018000 usd
CY2023Q1 us-gaap Investments
Investments
592000 usd
CY2022Q4 us-gaap Investments
Investments
3959000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-375000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2208000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
1400000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
500000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-400000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2200000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
600000 usd
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
600000 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
6400000 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
500000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13101000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6897000 usd
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1534000 usd
CY2022Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
1471000 usd
CY2023Q1 hska Lease Right Of Use Asset
LeaseRightOfUseAsset
14635000 usd
CY2022Q4 hska Lease Right Of Use Asset
LeaseRightOfUseAsset
8368000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4049000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2944000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9674000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
4528000 usd
CY2023Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
152000 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
127000 usd
CY2023Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
333000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
307000 usd
CY2023Q1 hska Lease Liability
LeaseLiability
14208000 usd
CY2022Q4 hska Lease Liability
LeaseLiability
7906000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9986000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10390000 shares
CY2023Q1 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
4995000 usd
CY2022Q1 us-gaap Sales Type Lease Revenue
SalesTypeLeaseRevenue
4101000 usd
CY2023Q1 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
3959000 usd
CY2022Q1 us-gaap Cost Of Goods Sold Sales Type Lease
CostOfGoodsSoldSalesTypeLease
3473000 usd
CY2023Q1 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
1036000 usd
CY2022Q1 us-gaap Sales Type Lease Selling Profit Loss
SalesTypeLeaseSellingProfitLoss
628000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
375000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
503000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-10125000 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10273000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10390000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10273000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1213000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1352000 shares
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
62393000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2500000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
135918000 usd
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
8359000 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1126000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
145403000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
91133000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25320000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
65813000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
85176000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
22783000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2200000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P7Y7M6D
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6712000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
8456000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
8411000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
8011000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
7074000 usd
CY2023Q1 hska Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
19719000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
58383000 usd
CY2023Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
7430000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
65813000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3412000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20866000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
96131000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
71892000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41101000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
39721000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
55030000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32171000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
1600000 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Period Increase Decrease
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentPeriodIncreaseDecrease
800000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15149000 usd
CY2023Q1 hska Percentage Of Total Liabilities Current
PercentageOfTotalLiabilitiesCurrent
0.05
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
23013000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
20978000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
5497000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
4102000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
35673000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34970000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
64183000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
60050000 usd
CY2023Q1 us-gaap Litigation Settlement Amount Awarded To Other Party
LitigationSettlementAmountAwardedToOtherParty
800000 usd
CY2023Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
45400000 usd
CY2023Q1 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
7287000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current And Noncurrent
AccruedEmployeeBenefitsCurrentAndNoncurrent
7908000 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
468000 usd
CY2022Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
670000 usd
CY2023Q1 hska Accrued Purchase Orders Current
AccruedPurchaseOrdersCurrent
1898000 usd
CY2022Q4 hska Accrued Purchase Orders Current
AccruedPurchaseOrdersCurrent
203000 usd
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
1558000 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
2123000 usd
CY2023Q1 hska Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
1755000 usd
CY2022Q4 hska Accrued Inventory In Transit Current
AccruedInventoryInTransitCurrent
677000 usd
CY2023Q1 hska Accrued Transaction Costs Current
AccruedTransactionCostsCurrent
5247000 usd
CY2022Q4 hska Accrued Transaction Costs Current
AccruedTransactionCostsCurrent
156000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2653000 usd
CY2023Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
300000 usd
CY2020Q1 hska Loss Contingency Post Contractual Non Compete Obligation Period
LossContingencyPostContractualNonCompeteObligationPeriod
P2Y
CY2023Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
1362000 usd
CY2022Q1 us-gaap Interest Income Deposits With Financial Institutions
InterestIncomeDepositsWithFinancialInstitutions
485000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
939000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
925000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-151000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
81000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
272000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-359000 usd
CY2023Q1 us-gaap Interest Paid
InterestPaid
1600000 usd
CY2022Q1 us-gaap Interest Paid
InterestPaid
2200000 usd
CY2023Q1 us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P3Y6M
CY2023Q1 us-gaap Share Price
SharePrice
97.62
CY2023Q1 hska Debt Instrument Value Exceeded Aggregate Amount If Converted
DebtInstrumentValueExceededAggregateAmountIfConverted
10900000 usd
CY2022Q4 us-gaap Derivative Asset Not Subject To Master Netting Arrangement
DerivativeAssetNotSubjectToMasterNettingArrangement
0 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Revenues
Revenues
62381000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
34982000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
27399000 usd
CY2023Q1 hska Gross Margin Percent
GrossMarginPercent
0.44
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-10423000 usd
CY2022Q1 us-gaap Revenues
Revenues
64800000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
35655000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
29145000 usd
CY2022Q1 hska Gross Margin Percent
GrossMarginPercent
0.45
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-11454000 usd
CY2023Q1 us-gaap Assets
Assets
592715000 usd
CY2022Q4 us-gaap Assets
Assets
585816000 usd

Files In Submission

Name View Source Status
0001038133-23-000023-index-headers.html Edgar Link pending
0001038133-23-000023-index.html Edgar Link pending
0001038133-23-000023.txt Edgar Link pending
0001038133-23-000023-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
heska-03312023xex31x1.htm Edgar Link pending
heska-03312023xex32x1.htm Edgar Link pending
hska-20230331_cal.xml Edgar Link unprocessable
hska-20230331_def.xml Edgar Link unprocessable
heska-03312023xexx31x2.htm Edgar Link pending
hska-20230331.htm Edgar Link pending
hska-20230331.xsd Edgar Link pending
hska-20230331_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
hska-20230331_lab.xml Edgar Link unprocessable
hska-20230331_pre.xml Edgar Link unprocessable
hska-20230331_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable